Dysregulated CD74 in macrophage-trophoblastic interactions and the pathogenesis of preeclampsia
Dysregulated CD74 in macrophage-trophoblastic interactions and the pathogenesis of preeclampsia
批准号:
195146839
负责人:
Privatdozent Dr. Florian Herse
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A better understanding of pathophysiologic mechanisms that lead to the development of preeclampsia is essential to develop new strategies for the prevention and the treatment. Trophoblastic activity and invasion are crucial to placental development; aberrancies in this process could lead to a pathological pregnancies and preeclampsia. Placental macrophages, the Hofbauer cells, regulate trophoblastic activity and direct or indirect contact between both cell types is essential for successful pregnancy. In preliminary work, we showed that the cluster of differentiation 74 (CD74) is downregulated in the preeclamptic placenta and localized CD74 in macrophages. Furthermore, downstream target factors of CD74 were also suppressed in the preeclamptic placenta. We propose that CD74 is involved in the development of preeclampsia and is a potential candidate for controlling cell-cell interaction between trophoblasts and macrophages. Thus, studies on CD74 and the macrophage-trophoblast interaction in pregnancy and preeclampsia are essential to enhance our knowledge of its modes of action and to evaluate its potential as a therapeutic agent in preeclampsia. Our global hypothesis is that a downregulated CD74 expression in placental macrophages is an underlying pathologic mechanism leading to preeclampsia. Specifically, we will pursue the following objectives: Objective 1:We will determine the underlying mechanisms of CD74 downregulation in the preeclamptic placenta. Objective 2:We will investigate the functional consequence of the CD74 downregulation on the macrophage-trophoblast interaction. Objective 3:We will determine the consequence of a CD74 downregulation in an animal model.Innovation:We will be the first to reveal the impact of CD74 in the macrophage-trophoblast interaction and the pathogenesis of preeclampsia, respectively. Our findings could lead to new mechanistic and therapeutic avenues for this devastating disease.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fendo.2018.00271
发表时间:
2018-05-29
期刊:
FRONTIERS IN ENDOCRINOLOGY
影响因子:
5.2
作者:
[Golic, Michaels, Kraker, Kristin, Dechend, Ralf]
通讯作者:
Dechend, Ralf
DOI:
10.1371/journal.pone.0150743
发表时间:
2016-03-10
期刊:
PLOS ONE
影响因子:
3.7
作者:
[Haase, Nadine, Golic, Michaela, Dechend, Ralf]
通讯作者:
Dechend, Ralf
DOI:
10.1161/hypertensionaha.116.07800
发表时间:
2016-10-01
期刊:
HYPERTENSION
影响因子:
8.3
作者:
[Golic, Michaela, Haase, Nadine, Dechend, Ralf]
通讯作者:
Dechend, Ralf
Characterization of Cell-Subpopulations in the preeclamptic placenta and decidua
-
批准号:400568798
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Florian Herse
-
依托单位:
Mechanisms of generation and maintenance of immune tolerance in pregnancy
-
批准号:320311956
-
项目类别:Scientific Networks
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Privatdozent Dr. Florian Herse
-
依托单位:
LYVE-1 Hofbauer cells in preeclampsia
-
批准号:327245046
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Privatdozent Dr. Florian Herse
-
依托单位:
国内基金
海外基金
登录
查看更多内容
苯乙酰谷氨酰胺PAGln通过靶向CD74调控B细胞分化在系统性红斑狼疮中的作用及机制研究
-
批准号:2026JJ60578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阮平浪
-
依托单位:
AQP-3下调CD74改善卵巢癌铂类化疗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋玲玲
-
依托单位:
CD74依赖的小胶质细胞新亚群通过调控OPC分化成熟影响慢性低灌注白质损伤中髓鞘修复的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黎义
-
依托单位:
鼻黏膜上皮细胞来源MIF靶向CD74调控巨噬细胞极化在CRSwNP组织EMT中的作用
-
批准号:2025JJ70644
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:童宗靖
-
依托单位:
SPP1+巨噬细胞通过 MIF/CD74 轴延迟老年小鼠伤口愈合的作用和机制研究
-
批准号:JCZRYB202501331
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基底细胞EMT 亚群通过 MIF-CD44/CD74 介导黏膜
下 Th 17/Treg 比例倒置促进 OSF 的机制
-
批准号:2024JJ5578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:郭峰
-
依托单位:
MIF/CD74介导M1型巨噬细胞调控混合密度磨玻璃样早期肺癌演化分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:张嘉涛
-
依托单位:
CD74高表达巨噬细胞亚群在曲妥珠单抗所致心脏毒性中的作用机制及药物干预研究
-
批准号:82373951
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈蓉
-
依托单位:
B7-H3/CD74介导T细胞耗竭促进肾癌免疫逃避的机理和功能研究
-
批准号:82373330
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:谌科
-
依托单位:
HNEpC来源外泌体搭载miR-1228-5p靶向MIF/CD74轴介导巨噬细胞M2极化调控EMT在CRSwNP中的作用
-
批准号:82301289
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:谢邵兵
-
依托单位: